[{"text": "Efficacy of a Rheumatoid Arthritis-Specific Smoking Cessation Program: A Randomized Controlled Pilot Trial", "labels": [], "entities": []}, {"text": "Smoking adversely influences comorbidities in rheumatoid arthritis (RA).", "labels": [], "entities": []}, {"text": "The aim of this pilot study was to investigate whether smoking cessation is increased following a 3 - month smoking cessation intervention tailored for people with RA.", "labels": [], "entities": [{"text": "smoking", "start_pos": 55, "end_pos": 62, "type": "Smoking", "confidence": 0.8473951816558838}]}, {"text": "Thirty-nine current smokers with RA were recruited.", "labels": [], "entities": []}, {"text": "Participants were randomized into the control group to receive the current local standard of care for smoking cessation (i.e., ABC 5 brief advice and subsidized nicotine replacement therapy [NRT], or into the intervention group to receive ABC plus additional smoking cessation advice for 3 months (ABC1), including face-to-face, telephone, and e-mail contact.", "labels": [], "entities": []}, {"text": "Advice was tailored to the participants' specific needs from a range of intervention tools focused on education about smoking and RA, pain control, exercise, coping, and support.", "labels": [], "entities": []}, {"text": "The primary outcome was smoking cessation at 6 months.", "labels": [], "entities": [{"text": "smoking", "start_pos": 24, "end_pos": 31, "type": "Smoking", "confidence": 0.9598240852355957}]}, {"text": "The secondary outcome was sustained reduction in smoking at 6 months.", "labels": [], "entities": [{"text": "smoking", "start_pos": 49, "end_pos": 56, "type": "Smoking", "confidence": 0.8471574187278748}]}, {"text": "Disease and psychosocial characteristics of quitters and nonquitters were examined.", "labels": [], "entities": []}, {"text": "The overall smoking cessation rate was 24%.", "labels": [], "entities": [{"text": "24", "start_pos": 39, "end_pos": 41, "type": "Outcome_value", "confidence": 0.945881724357605}]}, {"text": "There was no significant difference in smoking cessation rates between the ABC and ABC1 groups (21% versus 26%; P 5 0.70).", "labels": [], "entities": []}, {"text": "The mean number of cigarettes smoked daily was reduced by 44% (P < 0.001) but did not differ between ABC and ABC1 groups (mean reduction 47% versus 41%; P 5 0.72).", "labels": [], "entities": []}, {"text": "Successful quitters had more years in education and had smoked less across their lifetime, but these differences were not statistically significant.", "labels": [], "entities": []}, {"text": "Smoking cessation in RA may lead to a reduced comorbid burden.", "labels": [], "entities": [{"text": "Smoking", "start_pos": 0, "end_pos": 7, "type": "Smoking", "confidence": 0.7557083964347839}]}, {"text": "The lack of added benefit of the tailored intervention suggests that brief advice and NRT are currently the best practice for supporting people with RA who wish to quit smoking.", "labels": [], "entities": []}, {"text": "Smoking is recognized as the most important environmental risk factor in rheumatoid arthritis (RA) and increases the risk of important comorbidities associated with RA such as cardiorespiratory disease, cancer, serious infections, and osteoporosis.", "labels": [], "entities": []}, {"text": "The leading causes of death in RA are cardiovascular disease (CVD; 31%) and respiratory disease (29%) (1), with tobacco smoking an established risk factor for both of these conditions.", "labels": [], "entities": []}, {"text": "Recent studies have reported between 21 - 33% of individuals with RA are current smokers and between 50 - 75% are pastor current smokers (4 - 6).", "labels": [], "entities": []}, {"text": "Because smoking is a shared risk factor for RA and many of its comorbidities, people with RA experience the morbidity of a cumulative disease burden as well as excess mortality with the risk of premature death around 50% higher in RA than the general population.", "labels": [], "entities": []}, {"text": "Up to 90% of individuals with RA have 1 or more comorbidities and the risk increases with age and longer RA duration.", "labels": [], "entities": []}, {"text": "For individuals who have established RA, continued smoking may have a negative impact on comorbidities as well as on disease activity.", "labels": [], "entities": []}, {"text": "An increased risk of CVD in.", "labels": [], "entities": []}, {"text": "Supported by a Healthcare Delivery Partnership grant from the New Zealand Health Research Council and Arthritis New Zealand.", "labels": [], "entities": [{"text": "New", "start_pos": 112, "end_pos": 115, "type": "Lower-level_geographical_region", "confidence": 0.6794809103012085}, {"text": "Zealand", "start_pos": 116, "end_pos": 123, "type": "Country_of_intervention", "confidence": 0.8297646045684814}]}, {"text": "Additional funding was received from the University of Otago Research Fund.", "labels": [], "entities": []}, {"text": "RA has been associated with markers of disease severity, including rheumatoid factor (RF), anti-citrullinated protein antibody, radiographic progression, rheumatoid nodules, rheumatoid lung disease, vasculitis, and corticosteroid use (10).", "labels": [], "entities": []}, {"text": "Of particular importance, current smoking in RA has been independently linked with higher RF titers, worse radiographic damage and disability, poor clinical response, and failure to respond to treatments including methotrexate and tumor necrosis factor inhibitors.", "labels": [], "entities": []}, {"text": "This suggests that smoking and RA disease activity may act synergistically to increase the CVD risk in people with RA (10).", "labels": [], "entities": []}, {"text": "The prevalence of CVD in RA has been estimated to be 9.3%, with considerable variation between different countries.", "labels": [], "entities": []}, {"text": "Having RA almost doubles the risk of myocardial infarction within the first 10 years after the onset of RA (15).", "labels": [], "entities": []}, {"text": "The predicted risk of CVD for people with RA is similar to those without RA who are around 10 years older, and similar to individuals who have diabetes mellitus (10).", "labels": [], "entities": []}, {"text": "Therefore, due to the increased risk of premature death from CVD in RA and the connections between CVD and smoking, smoking cessation should bean important consideration in the management of RA.", "labels": [], "entities": []}, {"text": "Smoking cessation is known to have immediate cardiovascular benefits in as little as 24 hours due to rapid improvements in platelet aggregability and other factors relating to thrombosis.", "labels": [], "entities": [{"text": "Smoking", "start_pos": 0, "end_pos": 7, "type": "Smoking", "confidence": 0.6869509816169739}]}, {"text": "The risk of dying from CVD is halved within 1 year of quitting and reduced to that of a nonsmoker after 15 years smoke free (16).", "labels": [], "entities": []}, {"text": "While the benefits of smoking cessation in RA are likely to be reduced compared to the general population due to the inflammatory aspect of the disease, there is an assumption there will still be a benefit from quitting.", "labels": [], "entities": [{"text": "benefits of smoking cessation", "start_pos": 10, "end_pos": 39, "type": "5.3_Information_about_social_and_environmental_consequences", "confidence": 0.5049195736646652}]}, {"text": "This assumption of benefit from smoking cessation has been recognized by the European League Against Rheumatism (EULAR), as quitting smoking is 1 of the 10 recommendations proposed for managing the CVD risk in RA.", "labels": [], "entities": []}, {"text": "The lifetime risk of developing chronic obstructive pulmonary disease (COPD) is significantly higher in individuals who have RA compared to individuals without RA (9.6% versus 6.2%) and nearly 3 times higher in seropositive RA independent of smoking status.", "labels": [], "entities": [{"text": "chronic obstructive pulmonary disease (COPD)", "start_pos": 32, "end_pos": 76, "type": "Aggregate_health_status_type", "confidence": 0.7104510707514626}]}, {"text": "Moreover, the risk of developing COPD is up to 9 times higher in people with RA who smoke compared to those who have never smoked.", "labels": [], "entities": []}, {"text": "Because the risk of premature mortality from COPD in people with RA is 3 - fold compared to those without the disease, COPD contributes to the excess mortality found in RA (21).", "labels": [], "entities": []}, {"text": "Once developed, COPD cannot be cured, but further deterioration can be prevented by smoking cessation; therefore, increasing quit rates may reduce excess mortality due to COPD in RA.", "labels": [], "entities": []}, {"text": "Osteoporosis, the most common comorbidity in RA, has been reported to occur in 10 - 56% of all individuals with RA and is doubled in RA compared to the general population (23).", "labels": [], "entities": []}, {"text": "The increased risk of osteoporosis in RA is attributed to a number of factors including smoking, decreased mobility, and corticosteroid use.", "labels": [], "entities": []}, {"text": "Smoking is a known risk factor for osteoporotic fractures, and the risk increases linearly with increasing cigarette consumption.", "labels": [], "entities": []}, {"text": "Because smoking predisposes a patient to bone loss by direct and indirect cellular effects on bone cells involving all skeletal sites, smoking cessation may have a positive influence on bone mass.", "labels": [], "entities": []}, {"text": "Smoking cessation is a recommendation of the American College of Rheumatology (ACR) guidelines for the prevention of glucocorticoid-induced osteoporosis.", "labels": [], "entities": []}, {"text": "The benefits of smoking cessation for osteoporosis become apparent after 10 years of quitting when the risk of fracture is reduced (25).", "labels": [], "entities": [{"text": "benefits of smoking cessation", "start_pos": 4, "end_pos": 33, "type": "5.3_Information_about_social_and_environmental_consequences", "confidence": 0.5696007385849953}]}, {"text": "The higher risk of comorbid CVD, COPD, and osteoporosis associated with smoking in RA makes a compelling case for smoking cessation.", "labels": [], "entities": []}, {"text": "However, there has been little research undertaken regarding smoking cessation specifically in RA.", "labels": [], "entities": []}, {"text": "We have previously identified the barriers to smoking cessation in RA (28), and here we describe the translation of those observational findings about smoking cessation needs of individuals with RA into a novel intervention.", "labels": [], "entities": []}, {"text": "The aim of this study was to determine whether a targeted 3 - month smoking cessation intervention program tailored for people with RA increases smoking cessation rates at 6 months compared to standard smoking cessation advice.", "labels": [], "entities": []}, {"text": "Ethical approval was given by the Southern Health and Disability Ethics Committee.", "labels": [], "entities": []}, {"text": "All participants gave written informed consent.", "labels": [], "entities": []}, {"text": "The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN: 12612001076864) and was prospectively registered on October 8, 2012.", "labels": [], "entities": [{"text": "Australian", "start_pos": 34, "end_pos": 44, "type": "Country_of_intervention", "confidence": 0.6180357336997986}, {"text": "New", "start_pos": 45, "end_pos": 48, "type": "Lower-level_geographical_region", "confidence": 0.8394010663032532}, {"text": "Zealand", "start_pos": 49, "end_pos": 56, "type": "Country_of_intervention", "confidence": 0.5617846846580505}]}, {"text": "Participants were recruited from a single center in Christchurch, New Zealand.", "labels": [], "entities": [{"text": "Christchurch, New Zealand.", "start_pos": 52, "end_pos": 78, "type": "Lower-level_geographical_region", "confidence": 0.7640599250793457}]}, {"text": "Participants were eligible if they were age $18 years with a diagnosis of RA as defined by the 2010 ACR/EULAR criteria for RA and were current smokers (30).", "labels": [], "entities": []}, {"text": "Participants were randomized on a 1:1 ratio into the control or the intervention arms of the 6 - month study.", "labels": [], "entities": []}, {"text": "The sample size of 20 participants per study group was based on published guidelines for pilot studies.", "labels": [], "entities": []}, {"text": "A random allocation sequence allowing for 48 potential participants was generated by a biostatistician using an Excel spreadsheet in 6 blocks 3 8 allocations.", "labels": [], "entities": []}, {"text": "The smoking cessation intervention continued for 3 months, with followup at 3 and 6 months ().", "labels": [], "entities": [{"text": "6", "start_pos": 82, "end_pos": 83, "type": "Longest_follow_up", "confidence": 0.9663963317871094}]}, {"text": "The participants were enrolled into the study by the researcher (PA), who remained blinded to participant", "labels": [], "entities": []}, {"text": "Smoking is a risk factor for many comorbidities associated with rheumatoid arthritis (RA); therefore, people with RA experience the morbidity of a cumulative disease burden and a reduced life expectancy.", "labels": [], "entities": [{"text": "rheumatoid arthritis (RA)", "start_pos": 64, "end_pos": 89, "type": "Aggregate_health_status_type", "confidence": 0.6917994439601898}]}, {"text": "We found that a novel smoking cessation intervention tailored to RA was no more effective than usual care.", "labels": [], "entities": []}, {"text": "This suggested that brief advice and nicotine replacement therapy is the current best practice for supporting people with RA to quit smoking.", "labels": [], "entities": []}, {"text": "allocation until the 3 - month followup interview with all study participants.", "labels": [], "entities": []}, {"text": "Recruitment and data collection were conducted between November 2012 and March 2014.", "labels": [], "entities": []}, {"text": "The \"ABC\" (Ask, Brief advice, and Cessation support) smoking cessation pathway was provided to all participants by a rheumatology clinical nurse specialist trained in provision of this program.", "labels": [], "entities": []}, {"text": "The ABC pathway includes 3 key steps to help smokers quit (32): 1) ask about smoking status, 2) give brief advice to stop smoking to all smokers, and 3) provide evidence-based cessation support for those who wish to stop smoking.", "labels": [], "entities": [{"text": "brief advice to stop smoking", "start_pos": 101, "end_pos": 129, "type": "4.5._Advise_to_change_behavior", "confidence": 0.7288101196289063}]}, {"text": "This included offering nicotine replacement therapy (NRT) for 8 weeks to all participants.", "labels": [], "entities": [{"text": "nicotine replacement therapy", "start_pos": 23, "end_pos": 51, "type": "Somatic", "confidence": 0.7169430752595266}]}, {"text": "The smoking cessation intervention has been described in detail elsewhere.", "labels": [], "entities": [{"text": "smoking", "start_pos": 4, "end_pos": 11, "type": "Smoking", "confidence": 0.6936153769493103}]}, {"text": "In summary, a 3 - month tailored smoking cessation program was designed to address each of 5 previously identified RA-specific barriers to smoking cessation, namely lack of support, limited knowledge of the relationship between smoking and RA, uncontrolled pain, inability to exercise, and using smoking as a coping strategy (28).", "labels": [], "entities": []}, {"text": "The intervention was designed to be delivered by community-based arthritis educators trained in smoking cessation with the following key components: a telephone or face-to-face interview with each participant to determine their individual specific RA-related barriers to smoking cessation, and individualized education and support activities that addressed the 5 barriers.", "labels": [], "entities": []}, {"text": "The intervention also included 3 followup telephone calls, a support website, and 12 weekly smoking cessation advice e-mails.", "labels": [], "entities": [{"text": "telephone calls", "start_pos": 42, "end_pos": 57, "type": "Distance", "confidence": 0.820319652557373}]}, {"text": "The standard intervention pack included a novel educational handout that explained the effects of smoking on RA and noted that 1) smokers have an increased risk of developing RA, 2) smoking may reduce the effectiveness of some medication used to treat RA, 3) smoking may worsen joint damage, and 4) smoking leads to an increased risk of heart disease and osteoporosis for RA patients.", "labels": [], "entities": [{"text": "explained the effects of smoking on RA", "start_pos": 73, "end_pos": 111, "type": "5.1_Information_about_health_consequences", "confidence": 0.6788715507302966}]}, {"text": "Those randomized to the intervention arm were contacted by an arthritis educator to organize a needs assessment meeting that was undertaken within the same week as randomization into the study.", "labels": [], "entities": [{"text": "arthritis educator", "start_pos": 62, "end_pos": 80, "type": "Health_Professional", "confidence": 0.7757154107093811}]}, {"text": "This meeting included a discussion to assist the participants to set a quit date, to identify their own perceived barriers to quitting smoking, and to decide which intervention components would meet their individual goals and preferences.", "labels": [], "entities": [{"text": "set a quit date,", "start_pos": 65, "end_pos": 81, "type": "1.1.Goal_setting_(behavior)", "confidence": 0.9374889731407166}]}, {"text": "The primary outcome was self-reported smoking cessation at 6 months' postrandomization into the study.", "labels": [], "entities": [{"text": "self-reported", "start_pos": 24, "end_pos": 37, "type": "Self_report", "confidence": 0.9586057066917419}, {"text": "smoking", "start_pos": 38, "end_pos": 45, "type": "Smoking", "confidence": 0.8297280073165894}]}, {"text": "A participant was recorded as having quit smoking based on self-report, measured in days from their identified quit date with no subsequent smoking.", "labels": [], "entities": [{"text": "smoking", "start_pos": 42, "end_pos": 49, "type": "Smoking", "confidence": 0.7017577290534973}, {"text": "self-report", "start_pos": 59, "end_pos": 70, "type": "Self_report", "confidence": 0.9775652885437012}]}, {"text": "This measurement is continuous abstinence.", "labels": [], "entities": []}, {"text": "The recalled smoking status at 6 months' postrandomization was used for participants who had their 6 - month followup interview delayed longer than 1 month.", "labels": [], "entities": [{"text": "smoking", "start_pos": 13, "end_pos": 20, "type": "Smoking", "confidence": 0.8995068073272705}]}, {"text": "The secondary outcome was reduction in cigarette consumption at 6 months.", "labels": [], "entities": []}, {"text": "This was defined as the difference between the baseline daily cigarette smoking consumption and 6 - month daily cigarette consumption.", "labels": [], "entities": []}, {"text": "Data collection measures and verification.", "labels": [], "entities": []}, {"text": "Quantitative data were collected from all study participants at baseline, month 3, and month 6 from a variety of sources.", "labels": [], "entities": []}, {"text": "A participant's duration of RA, comorbidities, and use of diseasemodifying antirheumatic drugs were extracted from hospital records and from self-reporting.", "labels": [], "entities": []}, {"text": "Age, sex, ethnicity, level of formal education, employment status, any joint surgery, and smoking history were self-reported.", "labels": [], "entities": []}, {"text": "Standardized questionnaires on health status and smoking history were used along with the Health Assessment Questionnaire (HAQ) (34), the personal impact HAQ (35), the Arthritis Self-Efficacy Scale (36), the Hospital Anxiety and Depression Scale (37), the Perceived Stress Scale (38), the EuroQol (EQ) 5 - domain measure (39), the EQ visual analog scale (EQ-VAS) (40), the Smoking Self-Efficacy Questionnaire (41), a smoking history questionnaire, and the Fagerstr\u20ac om Test for Nicotine Dependency (FTND) (42).", "labels": [], "entities": []}, {"text": "Between-group comparisons for primary and secondary outcomes were undertaken utilizing an intent-to-treat approach.", "labels": [], "entities": []}, {"text": "Statistical analysis using SPSS software employed one-way analysis of variance, chisquare (x 2 ) tests, or Fisher's exact test of independence.", "labels": [], "entities": []}, {"text": "The CONSORT (Consolidated Standards of Reporting Trials) flow diagram is illustrated in.", "labels": [], "entities": []}, {"text": "One control participant did not have RA.", "labels": [], "entities": []}, {"text": "Three intervention participants withdrew from the study after completing the 12 - week intervention period.", "labels": [], "entities": []}, {"text": "Two participants withdrew at 3 months and 1 at 6 months because they no longer wished to quit smoking.", "labels": [], "entities": []}, {"text": "Twenty-six study participants were interviewed at 3 months and all of the remaining study participants (n 5 35) were interviewed at 6 months.", "labels": [], "entities": []}, {"text": "There were no statistically significant differences between the intervention and control groups in demographics or disease characteristics including disability levels or physiologic impact of RA.", "labels": [], "entities": []}, {"text": "Self-efficacy over mood or other symptoms of arthritis, anxiety, depression, and stress were similar for both groups.", "labels": [], "entities": []}, {"text": "The EQ-VAS scores were similar, suggesting both groups.", "labels": [], "entities": []}, {"text": "ABC 5 brief advice and subsidized nicotine replacement therapy.", "labels": [], "entities": []}, {"text": "ABC1 5 brief advice and subsidized nicotine replacement therapy plus additional smoking cessation advice for 3 months.", "labels": [], "entities": []}, {"text": "Aimer et al had a positive perception of their health status.", "labels": [], "entities": []}, {"text": "The lack of difference in smoking self-efficacy demonstrates the similarities in these study groups with regard to their ability to refrain from smoking.", "labels": [], "entities": []}, {"text": "Both study groups were similar in their smoking history regarding pack-years of smoking.", "labels": [], "entities": []}, {"text": "The FTND indicated the participants had moderate dependency on nicotine.", "labels": [], "entities": []}, {"text": "Nearly all of the participants reported having received advice from a health practitioner to quit smoking within the last year (.", "labels": [], "entities": [{"text": "health practitioner", "start_pos": 70, "end_pos": 89, "type": "Health_Professional", "confidence": 0.7755531072616577}]}, {"text": "Fourteen of 19 intervention and 15 of 19 control patients used NRT.", "labels": [], "entities": []}, {"text": "Five participants had adverse reactions to NRT, including nightmares (n 5 2: 1 intervention, 1 control), localized skin reactions to the patches (n 5 2: 1 intervention, 1 control), and erectile dysfunction (n 5 1 control).", "labels": [], "entities": []}, {"text": "At 6 months there was no significant difference in smoking cessation rates between the intervention and control participants (5 of 19 [26%] versus 4 of 19 [21%]; P 5 0.70); difference in percentages was 5.83 (95% confidence interval [95% CI] 224.6, 34.1) ().", "labels": [], "entities": []}, {"text": "The average continuous abstinence rate was 125 days (range 7 - 179 days) among the participants who quit smoking.", "labels": [], "entities": []}, {"text": "Based on these data, the sample size for an adequately powered (95%) randomized controlled trial (RCT) would be 3,472 participants.", "labels": [], "entities": []}, {"text": "There was no statistically significant difference between the number of cigarettes smoked per day at baseline and 6 months in either group (.", "labels": [], "entities": []}, {"text": "The overall percent reduction in number of cigarettes smoked per day was similar for both groups, and ranged from 20% to 96% for those participants who cut down their daily smoking consumption (11 of 38 participants).", "labels": [], "entities": [{"text": "20", "start_pos": 114, "end_pos": 116, "type": "Outcome_value", "confidence": 0.8372983336448669}]}, {"text": "The absolute reduction in number of cigarettes smoked by the study participants as a group equated to 276 less cigarettes everyday, or over 100,000 cigarettes on an annual basis.", "labels": [], "entities": []}, {"text": "Exploratory analyses were undertaken to identify any factors that predicted smoking cessation.", "labels": [], "entities": [{"text": "smoking", "start_pos": 76, "end_pos": 83, "type": "Smoking", "confidence": 0.7458468079566956}]}, {"text": "There was no observed difference in quitting rates between participants with disease duration less than 2 years compared to those with a longer disease duration (P 5 0.74).", "labels": [], "entities": []}, {"text": "NRT was used by more quitters (89%) than nonquitters (69%), but this did not reach statistical significance (P 5 0.60).", "labels": [], "entities": []}, {"text": "There were no other baseline demographic, disease, or psychosocial factors associated with smoking cessation, although successful quitters showed a trend toward having a greater number of years in education beyond high school (P 5 0.06) and had smoked less across their lifetime (P 5 0.07).", "labels": [], "entities": []}, {"text": "* Values are the number (percentage) or mean 6 SD unless indicated otherwise.", "labels": [], "entities": []}, {"text": "ACPA 5 anti-cyclic citrullinated peptide antibody; RF 5 rheumatoid factor; DMARDs 5 disease-modifying antirheumatic drugs; NSAIDs 5 nonsteroidal antirheumatic drugs; CVD 5 cardiovascular disease, defined as ischemic heart disease, angina, myocardial infarction; COPD 5 chronic obstructive pulmonary disease; CRP 5 Creactive protein; IQR 5 interquartile range; HAQ 5 Health Assessment Questionnaire; EQ-VAS 5 EuroQol visual analog scale; EQ-5D 5 EuroQol 5 - domain measure; ASES 5 Arthritis Self-Efficacy Scale; HADS 5 Hospital Anxiety and Depression Scale; PSS 5 Perceived Stress Scale.", "labels": [], "entities": []}, {"text": "It has been well recognized that comorbid CVD and osteoporosis are overrepresented in people with RA, leading to increased morbidity and mortality that could be improved with smoking cessation.", "labels": [], "entities": []}, {"text": "In clinical research, pilot studies provide an essential first step for exploring novel interventions and are useful to inform feasibility and identity potential protocol modifications fora full RCT (43).", "labels": [], "entities": []}, {"text": "This pilot study was designed to assess the efficacy of a novel,  CRP 5 C-reactive protein; IQR 5 interquartile range; ASES 5 Arthritis Self-Efficacy Scale; HADS 5 Hospital Anxiety and Depression Scale; PSS 5 Perceived Stress Scale; HAQ 5 Health Assessment Questionnaire; EQ-VAS 5 EuroQol visual analog scale; EQ-5D 5 EuroQol 5 - domain measure; CVD 5 cardiovascular disease, defined as ischemic heart disease, angina, myocardial infarction; COPD 5 chronic obstructive pulmonary disease; ACPA 5 anti-cyclic citrullinated peptide antibody; RF 5 rheumatoid factor; DMARDs 5 disease-modifying antirheumatic drugs; NSAIDs 5 nonsteroidal antirheumatic drugs.", "labels": [], "entities": []}, {"text": "\u2020 Fisher's exact test of independence.", "labels": [], "entities": []}, {"text": "tailored smoking cessation intervention for people with RA.", "labels": [], "entities": []}, {"text": "The intervention was grounded in previous research, was informed by participant opinion, provided support and advice from trained arthritis educations, and incorporated evidence-based smoking cessation treatments.", "labels": [], "entities": []}, {"text": "No statistically significant differences between quit rates at 6 months were demonstrated between the tailored intervention and standard smoking cessation advice, nor was there a difference in sustained reduction in the number of cigarettes smoked per day.", "labels": [], "entities": []}, {"text": "However, overall quit rates were high at 26% and 21%, respectively, indicating the intervention itself was successful in comparison with data on no intervention (44).", "labels": [], "entities": [{"text": "26", "start_pos": 41, "end_pos": 43, "type": "Outcome_value", "confidence": 0.9151146411895752}, {"text": "21", "start_pos": 49, "end_pos": 51, "type": "Outcome_value", "confidence": 0.9328596591949463}]}, {"text": "By comparing the quit rates from other studies of similar intervention intensity and/or similar study populations, it is apparent that both arms of this smoking cessation intervention achieved a high quit rate at an average of 24%.", "labels": [], "entities": [{"text": "24", "start_pos": 227, "end_pos": 229, "type": "Outcome_value", "confidence": 0.9003892540931702}]}, {"text": "Intensive clinical smoking cessation programs provided by the National Health Service for the general population in the UK were routinely monitored from 2003 - 2007, thereby providing an overview of the treatment of over 2 million smokers in a clinical setting (45).", "labels": [], "entities": [{"text": "UK", "start_pos": 120, "end_pos": 122, "type": "Country_of_intervention", "confidence": 0.9743845462799072}]}, {"text": "A systematic review in 2010 found this program resulted in 15% abstinence at 1 year (45).", "labels": [], "entities": []}, {"text": "Although the length of followup differs from our study (1 year versus 6 months), it is recognized that smokers are most likely to relapse in the first 6 months following treatment rather than the second 6 months (46).", "labels": [], "entities": []}, {"text": "Changing entrenched smoking habits is difficult for smokers, and most attempt to quit many times before succeeding.", "labels": [], "entities": []}, {"text": "Surveys in the US have consistently reported 70% of smokers want to quit; nearly half of these will have attempted during the previous year but only 4 - 7% are successful (47).", "labels": [], "entities": [{"text": "US", "start_pos": 15, "end_pos": 17, "type": "Country_of_intervention", "confidence": 0.9849761128425598}]}, {"text": "People with RA have described how it is difficult to focus on behaviors such as smoking cessation at the time of diagnosis because of ongoing pain, fatigue, and stress (48).", "labels": [], "entities": []}, {"text": "There are also practical issues of frequent doctor visits and starting new medications.", "labels": [], "entities": []}, {"text": "The only study published to date of a smoking intervention designed specifically for patients with rheumatic diseases was a prospective study with an educational intervention in a single hospital in Spain.", "labels": [], "entities": [{"text": "Spain", "start_pos": 199, "end_pos": 204, "type": "Country_of_intervention", "confidence": 0.9801638722419739}]}, {"text": "Quit rates of 11.8% at 3 months and 15.7% at 12 months, respectively, were reported, compared to unassisted quitting rates of 4.6% over the past 5 years in the same patient population (49).", "labels": [], "entities": []}, {"text": "In that study patients with a variety of rheumatic diseases, not just RA, were included.", "labels": [], "entities": []}, {"text": "Participants received brief verbal and written advice (3 - 5 minutes) from a rheumatologist, designed to be given at the end of regular medical visits.", "labels": [], "entities": []}, {"text": "The advice included general benefits of quitting smoking plus advice describing potential benefits in reduced CVD risks and the development of rheumatic diseases from smoking (49).", "labels": [], "entities": []}, {"text": "This was followed by an intensive 20 - minute session of verbal and written advice from a rheumatology nurse, designed to detect individual barriers for not quitting.", "labels": [], "entities": [{"text": "rheumatology nurse", "start_pos": 90, "end_pos": 108, "type": "Health_Professional", "confidence": 0.7149502038955688}]}, {"text": "Varenicline, a nicotine receptor partial agonist, was offered to patients with high nicotine dependence as per their standard practice, but NRT was not offered.", "labels": [], "entities": []}, {"text": "Followup consisted of a telephone call in the third month that included further motivational advice (49).", "labels": [], "entities": [{"text": "telephone call", "start_pos": 24, "end_pos": 38, "type": "Distance", "confidence": 0.9016060829162598}]}, {"text": "However, the context of the Spanish study means it is difficult to compare their findings to our study.", "labels": [], "entities": []}, {"text": "In New Zealand, the use of NRT is widespread because it is an essential component of the ABC pathway and its efficacy as a pharmacologic smoking cessation aid has been firmly established (50).", "labels": [], "entities": [{"text": "New", "start_pos": 3, "end_pos": 6, "type": "Lower-level_geographical_region", "confidence": 0.8724920749664307}, {"text": "Zealand", "start_pos": 7, "end_pos": 14, "type": "Country_of_intervention", "confidence": 0.682952880859375}]}, {"text": "If NRT had been routinely offered in the Spanish study, higher quit rates might have been expected than were observed.", "labels": [], "entities": []}, {"text": "The authors suggested the brief disease-specific educational component added to the initial rheumatologist consultation aided cessation (49).", "labels": [], "entities": []}, {"text": "In the current pilot study, the complex nature of the intervention components meant that it was not possible to separately identify whether this contributed to quitting rates alone or in combination with the use of NRT.", "labels": [], "entities": []}, {"text": "Also, because of the inclusion of a heterogeneous population of patients with various rheumatic diseases in the Spanish trial, a direct comparison with the current study is not possible.", "labels": [], "entities": []}, {"text": "In this pilot study, a trend toward a higher level of education attainment in those who successfully quit compared to nonquitters was noted, although this did not reach statistical significance (P 5 0.06).", "labels": [], "entities": []}, {"text": "This finding is similar to smoking cessation studies undertaken in the general population where demographic barriers to quitting smoking include less educational attainment (51).", "labels": [], "entities": [{"text": "smoking", "start_pos": 27, "end_pos": 34, "type": "Smoking", "confidence": 0.7462695240974426}]}, {"text": "There was also a trend for participants who had a longer history of smoking to be less likely to quit in this study (P 5 0.07).", "labels": [], "entities": []}, {"text": "The pack-year history averaged 42 years for nonquitters, as opposed to 26 years for quitters despite the similar mean ages of each group (55.2 years for quitters versus 56.9 years for nonquitters).", "labels": [], "entities": [{"text": "42", "start_pos": 31, "end_pos": 33, "type": "Mean_age", "confidence": 0.8217816948890686}]}, {"text": "Thus, either the nonquitters initiated smoking at a younger age or they were smoking more heavily.", "labels": [], "entities": []}, {"text": "The number of cigarettes smoked per day has been shown to affect smoking cessation behavior, where those who smoke a higher number of cigarettes are less likely to quit smoking (51).", "labels": [], "entities": [{"text": "smoking", "start_pos": 65, "end_pos": 72, "type": "Smoking", "confidence": 0.7177777886390686}]}, {"text": "Measuring a sustained reduction in daily smoking was the secondary outcome from this pilot study.", "labels": [], "entities": []}, {"text": "Previous studies have confirmed the positive benefit of $50% reduction of smoking on established CVD risk factors.", "labels": [], "entities": []}, {"text": "An open study measured the effects of 8 weeks of reduced smoking prior to a smoking cessation attempt at 9 weeks on serologic markers of CVD risk (including fibrinogen, triglycerides, and cholesterol).", "labels": [], "entities": [{"text": "smoking", "start_pos": 76, "end_pos": 83, "type": "Smoking", "confidence": 0.8039326667785645}]}, {"text": "After 8 weeks of smoking reduction there were clinically significant improvements in these serologic parameters (52).", "labels": [], "entities": []}, {"text": "The smoking cessation intervention in this pilot study incorporated a combination of internationally recognized best-practice, evidence-based smoking cessation treatments in an attempt to achieve the highest possible rates of smoking cessation during the intervention period.", "labels": [], "entities": []}, {"text": "At the same time, the study aimed to tailor the intervention components to meet the stated needs of individual participants.", "labels": [], "entities": []}, {"text": "The Cochrane Collaboration systematic reviews have established the most efficacious smoking cessation treatments that include a combination of pharmacotherapy and behavioral interventions, which can demonstrate a doubled quitting rate (risk ratio: 1.82, 95% CI 1.66, 2.00) compared to brief advice alone (8%).", "labels": [], "entities": []}, {"text": "The intervention in this study incorporated the recommendations for evidence-based smoking cessation treatments.", "labels": [], "entities": []}, {"text": "The high rate of smoking cessation in both study groups and the lack of significant difference in quit rates could", "labels": [], "entities": []}, {"text": "Aimer et al have been the result of several factors.", "labels": [], "entities": []}, {"text": "Selection bias was highly likely because the participants who agreed to take part in this study were likely to be motivated to quit smoking regardless of their study allocation.", "labels": [], "entities": []}, {"text": "It is equally possible that those individuals who declined to participate in this study did so because they had no intention or desire to quit smoking.", "labels": [], "entities": []}, {"text": "Furthermore, the relationships between smoking and RA was discussed with all potential participants at the stage of consent and this information could have provided an unintended educational intervention and an extra motivation for control group participants to quit.", "labels": [], "entities": []}, {"text": "Although both factors probably played apart in this study, another source of the high quitting rate of all participants was the use of NRT as a common treatment.", "labels": [], "entities": []}, {"text": "The success of using NRT to help smokers quit has led to its use being recommended as first-line treatment in many international clinical guidelines, including the ABC pathway for smoking cessation in New Zealand (50).", "labels": [], "entities": [{"text": "New", "start_pos": 201, "end_pos": 204, "type": "Lower-level_geographical_region", "confidence": 0.8901971578598022}, {"text": "Zealand", "start_pos": 205, "end_pos": 212, "type": "Country_of_intervention", "confidence": 0.7003839612007141}]}, {"text": "In addition to NRT, the ABC pathway also incorporated brief advice, which independently increases the chances of quitting smoking by nearly double again.", "labels": [], "entities": []}, {"text": "Thus, the primary outcome quit rates of 26% versus 21% in the intervention and control groups in this pilot study were a reflection of the success of the \"usual care\" treatment of using NRT in combination with brief advice.", "labels": [], "entities": []}, {"text": "Overall, the combination of these factors suggests the pilot study findings may only be generalizable to highly motivated individuals and not to individuals who do not have any motivation to quit smoking.", "labels": [], "entities": []}, {"text": "There are several strengths of this study.", "labels": [], "entities": []}, {"text": "Exclusion criteria for entry into this study were kept to a minimum, thus reducing selection bias (54).", "labels": [], "entities": []}, {"text": "The key role of the arthritis educators and the support network from Arthritis New Zealand were important strengths.", "labels": [], "entities": [{"text": "New", "start_pos": 79, "end_pos": 82, "type": "Lower-level_geographical_region", "confidence": 0.5586161613464355}, {"text": "Zealand", "start_pos": 83, "end_pos": 90, "type": "Country_of_intervention", "confidence": 0.8955578804016113}]}, {"text": "The educators are experienced in providing support and advice to people with RA, and the pilot study intervention was designed to fit within their existing service delivery structure and was based where possible upon existing resources and information from Arthritis New Zealand.", "labels": [], "entities": []}, {"text": "The wide range of intervention components offered to participants was a key intervention strength because of the ability to tailor to each participant, while providing facilitators for both the management of RA and smoking cessation.", "labels": [], "entities": []}, {"text": "The study had several limitations.", "labels": [], "entities": []}, {"text": "Pilot studies are primarily designed to address the feasibility and methodology of study protocols, and to ascertain future CIs for power analyses fora fully powered study in relation to the chosen primary outcome.", "labels": [], "entities": []}, {"text": "They are not powered statistically to assess between-group differences in chosen outcomes (55).", "labels": [], "entities": []}, {"text": "Despite this, the sample size in this pilot study was adequate based on published guidelines.", "labels": [], "entities": []}, {"text": "Self-reporting of smoking status and self-reporting of quit dates can also be a source of error due to recall bias (56).", "labels": [], "entities": []}, {"text": "Future studies could measure serum cotinine or a carbon monoxide breath test as a formal test of exposure to smoke.", "labels": [], "entities": [{"text": "serum cotinine", "start_pos": 29, "end_pos": 43, "type": "Biochemical_verification", "confidence": 0.7699729204177856}, {"text": "carbon monoxide breath test", "start_pos": 49, "end_pos": 76, "type": "Biochemical_verification", "confidence": 0.8065021559596062}]}, {"text": "The delay in some 6 - month followup interviews could have been a source of recall bias error as the participants may not have remembered their exact smoking status at that time point.", "labels": [], "entities": [{"text": "smoking", "start_pos": 150, "end_pos": 157, "type": "Smoking", "confidence": 0.776237964630127}]}, {"text": "Recall bias could have occurred with participant's recollections of recognizing the specific interventions that were provided during the first week of the study.", "labels": [], "entities": []}, {"text": "Another limitation is the study only used a relatively brief followup period and no data were gathered on changes in the presence, severity, or burden of comorbidities, such as CVD and osteoporosis.", "labels": [], "entities": []}, {"text": "However, the efficacy of the smoking intervention as a whole that is presented here shows the potential for preventing or reducing the disease burden related to comorbidities in RA.", "labels": [], "entities": []}, {"text": "This pilot study evaluated the efficacy of an individually tailored smoking cessation program for people with RA.", "labels": [], "entities": []}, {"text": "Although the tailored intervention was no more effective than usual care, the smoking cessation rate was high in both groups compared to previous smoking cessation studies, suggesting brief advice and NRT as provided in the ABC pathway is currently the best practice for supporting people with RA who wish to quit smoking.", "labels": [], "entities": [{"text": "tailored intervention", "start_pos": 13, "end_pos": 34, "type": "Arm_name", "confidence": 0.7127000689506531}]}, {"text": "Those with less educational attainment and a longer lifetime of smoking may require particular assistance with quitting.", "labels": [], "entities": []}, {"text": "There is the possibility that the educational component from the intervention had a larger effect than was recognized; therefore RA-specific information about smoking given in addition to brief cessation advice maybe beneficial.", "labels": [], "entities": []}, {"text": "Because smoking has a direct and significant impact on RA, particularly the risk of increased comorbidity and premature mortality, assisting people with RA with smoking cessation is an essential aspect of clinical care.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Category/measurement: (n of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 5 19).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Category/measurement: (n: 12 (63): (n of Comparison of baseline data between the intervention and control groups*: Control has a value of 5 19).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Category/measurement: (n: 12 (63): (n: (n of Comparison of baseline data between the intervention and control groups*: Total has a value of 5 38).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Category/measurement of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 56.0.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Category/measurement of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Category/measurement of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 12.1.", "labels": [], "entities": [{"text": "12.1", "start_pos": 159, "end_pos": 163, "type": "Outcome_value", "confidence": 0.724256694316864}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 57.0.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 11.9.", "labels": [], "entities": [{"text": "11.9", "start_pos": 145, "end_pos": 149, "type": "Outcome_value", "confidence": 0.7363505363464355}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 56.5.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 11.8.", "labels": [], "entities": [{"text": "11.8", "start_pos": 143, "end_pos": 147, "type": "Outcome_value", "confidence": 0.7428165078163147}]}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 8.2.", "labels": [], "entities": [{"text": "8.2", "start_pos": 141, "end_pos": 144, "type": "Outcome_value", "confidence": 0.6500750780105591}]}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 10.1.", "labels": [], "entities": [{"text": "10.1", "start_pos": 141, "end_pos": 145, "type": "Outcome_value", "confidence": 0.7608106136322021}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 7.2.", "labels": [], "entities": [{"text": "7.2", "start_pos": 145, "end_pos": 148, "type": "Outcome_value", "confidence": 0.6454765200614929}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 6.3.", "labels": [], "entities": [{"text": "6.3", "start_pos": 145, "end_pos": 148, "type": "Outcome_value", "confidence": 0.638054609298706}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 7.7.", "labels": [], "entities": [{"text": "7.7", "start_pos": 143, "end_pos": 146, "type": "Outcome_value", "confidence": 0.6658483743667603}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 8.4.", "labels": [], "entities": [{"text": "8.4", "start_pos": 143, "end_pos": 146, "type": "Outcome_value", "confidence": 0.6755152940750122}]}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 12.2.", "labels": [], "entities": [{"text": "12.2", "start_pos": 141, "end_pos": 145, "type": "Outcome_value", "confidence": 0.7354297637939453}]}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 1.9.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 11.3.", "labels": [], "entities": [{"text": "11.3", "start_pos": 145, "end_pos": 149, "type": "Outcome_value", "confidence": 0.7448092103004456}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 1.0.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 11.7.", "labels": [], "entities": [{"text": "11.7", "start_pos": 143, "end_pos": 147, "type": "Outcome_value", "confidence": 0.7389556169509888}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 1.5.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 5.2.", "labels": [], "entities": [{"text": "5.2", "start_pos": 141, "end_pos": 144, "type": "Outcome_value", "confidence": 0.5834730863571167}]}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention has a value of 2.8.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 5.0.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 2.9.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 5.5.", "labels": [], "entities": [{"text": "5.5", "start_pos": 143, "end_pos": 146, "type": "Outcome_value", "confidence": 0.5220194458961487}]}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total has a value of 2.7.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control has a value of 9 (47).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 11 (58) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90) has a value of 8 (42).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 2 (11).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 2 (11).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 4 (11).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 8 (42).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 9 (47).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: Prednisone: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 9 (47).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: CVD of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 2 (11).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: CVD: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 2 (11).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: CVD: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 4 (11).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: COPD of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 2 (11).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: COPD: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 1 (5).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: COPD: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 3 (8).", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation score: Osteoporosis of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 4 (21).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: Osteoporosis: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 3 (16).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: Osteoporosis: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 7 (18).", "labels": [], "entities": []}, {"text": "The Previous joint surgery: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 3 (16).", "labels": [], "entities": []}, {"text": "The Previous joint surgery: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 1 (5).", "labels": [], "entities": []}, {"text": "The Previous joint surgery: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 4 (11).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 3 (3 - 21).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 4 (3 - 8).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 4 (3 - 8).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 1.0.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 0.8.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 0.6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 0.6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 0.8.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 0.7.", "labels": [], "entities": []}, {"text": "The EQ-VAS: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 69.4.", "labels": [], "entities": []}, {"text": "The EQ-VAS: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The EQ-VAS: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 17.3.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 74.8.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 19.5.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 72.1.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 18.4.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 0.6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 0.2.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 0.7.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 0.2.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 0.7.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 0.2.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 2.6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 2.0.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 2.1.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 2.0.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 2.3.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 2.0.", "labels": [], "entities": []}, {"text": "The ASES pain: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 5.9.", "labels": [], "entities": []}, {"text": "The ASES pain: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES pain: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 1.7.", "labels": [], "entities": []}, {"text": "The ASES pain: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.7.", "labels": [], "entities": []}, {"text": "The ASES pain: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES pain: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 2.1.", "labels": [], "entities": []}, {"text": "The ASES pain: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.3.", "labels": [], "entities": []}, {"text": "The ASES pain: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES pain: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 2.0.", "labels": [], "entities": []}, {"text": "The ASES mood: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 7.0.", "labels": [], "entities": []}, {"text": "The ASES mood: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES mood: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 2.1.", "labels": [], "entities": []}, {"text": "The ASES mood: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 7.5.", "labels": [], "entities": []}, {"text": "The ASES mood: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES mood: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 2.1.", "labels": [], "entities": []}, {"text": "The ASES mood: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 7.2.", "labels": [], "entities": []}, {"text": "The ASES mood: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES mood: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 2.1.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.4.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 3.7.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 7.1.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 3.9.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.7.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 3.8.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 4.1.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 3.1.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 5.0.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 3.3.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 4.5.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 3.2.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 22.7.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 8.7.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 20.6.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 8.4.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 21.7.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 8.5.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 13.5.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.1.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 12.5.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.4.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 13.0.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.2.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 13.6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 5.2.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 14.1.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.1.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 13.8.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 5.6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 16.6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 8.2.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 16.4.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.9.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 16.5.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 7.5.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 40.6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 12.2.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 41.7.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 12.0.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 41.2.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 12.0.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 4.0.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 1.6.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 4.0.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 2.2.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 4.0.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 1.9.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 38.1.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 27.3.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 37.4.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 18.5.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 37.8.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter*: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Total: 34 (90): 34 (90): 30 (79): 27 (71): 34 (89) has a value of 22.9.", "labels": [], "entities": [{"text": "22.9", "start_pos": 225, "end_pos": 229, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.6427573561668396}]}, {"text": "The Exposed to indoor tobacco smoke at home of Comparison of baseline data between the intervention and control groups*: Intervention: 17 (90): 18 (95): 17 (90): 15 (79): 16 (84) has a value of 4 (21).", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor tobacco smoke at home: 12 (63) of Comparison of baseline data between the intervention and control groups*: Control: 17 (90): 16 (84): 13 (68): 12 (63): 18 (95) has a value of 8 (42).", "labels": [], "entities": []}, {"text": "The Quit smoking of Primary and secondary pilot study outcomes*: Intervention has a value of 5 (26).", "labels": [], "entities": []}, {"text": "The Quit smoking of Primary and secondary pilot study outcomes*: Control has a value of 4 (21).", "labels": [], "entities": []}, {"text": "The Quit smoking of Primary and secondary pilot study outcomes*: Overall has a value of 9 (24).", "labels": [], "entities": []}, {"text": "The Quit smoking of Primary and secondary pilot study outcomes*: P has a value of 0.70.", "labels": [], "entities": []}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Intervention has a value of 16.6.", "labels": [], "entities": [{"text": "16.6", "start_pos": 110, "end_pos": 114, "type": "Outcome_value", "confidence": 0.6030822992324829}]}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Intervention has a value of 6.", "labels": [], "entities": []}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Intervention has a value of 8.2.", "labels": [], "entities": [{"text": "8.2", "start_pos": 110, "end_pos": 113, "type": "Outcome_value", "confidence": 0.6233116388320923}]}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Control has a value of 16.4.", "labels": [], "entities": [{"text": "16.4", "start_pos": 105, "end_pos": 109, "type": "Outcome_value", "confidence": 0.5253855586051941}]}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Control has a value of 6.", "labels": [], "entities": []}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Control has a value of 7.0.", "labels": [], "entities": [{"text": "7.0", "start_pos": 105, "end_pos": 108, "type": "Outcome_value", "confidence": 0.578789234161377}]}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Overall has a value of 16.5.", "labels": [], "entities": [{"text": "16.5", "start_pos": 105, "end_pos": 109, "type": "Outcome_value", "confidence": 0.5488555431365967}]}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Overall has a value of 6.", "labels": [], "entities": []}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Overall has a value of 7.5.", "labels": [], "entities": [{"text": "7.5", "start_pos": 105, "end_pos": 108, "type": "Outcome_value", "confidence": 0.5572847723960876}]}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: P has a value of 0.92.", "labels": [], "entities": []}, {"text": "The  of Table 2.: Intervention has a value of 6 months (no. cigarettes/day).", "labels": [], "entities": []}, {"text": "The Baseline (no. cigarettes/day) of Primary and secondary pilot study outcomes*: Intervention has a value of 9.9.", "labels": [], "entities": [{"text": "9.9", "start_pos": 110, "end_pos": 113, "type": "Outcome_value", "confidence": 0.6229571104049683}]}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Intervention has a value of 6.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Intervention has a value of 10.7.", "labels": [], "entities": [{"text": "10.7", "start_pos": 125, "end_pos": 129, "type": "Outcome_value", "confidence": 0.6555272936820984}]}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Control has a value of 8.6.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Control has a value of 6.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Control has a value of 6.7.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Overall has a value of 9.3.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Overall has a value of 6.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Overall has a value of 8.8.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: P has a value of 0.67.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Primary and secondary pilot study outcomes*: Control: 47 has a value of 6 SD unless indicated otherwise..", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: psychosocial factors: (n of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 5 9).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: psychosocial factors: (n: (n of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 5 29).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 25.6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 10.4.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 41.7.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 24.5.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: Cumulative pack-years of smoking: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.07.", "labels": [], "entities": []}, {"text": "The Education, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 12.6.", "labels": [], "entities": []}, {"text": "The Education, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Education, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 1.9.", "labels": [], "entities": []}, {"text": "The Education, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 11.5.", "labels": [], "entities": []}, {"text": "The Education, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Education, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.3.", "labels": [], "entities": []}, {"text": "The Education, years: Cumulative pack-years of smoking: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.06.", "labels": [], "entities": []}, {"text": "The Current age, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 55.2.", "labels": [], "entities": []}, {"text": "The Current age, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Current age, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 12.3.", "labels": [], "entities": []}, {"text": "The Current age, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 56.9.", "labels": [], "entities": []}, {"text": "The Current age, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Current age, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 11.8.", "labels": [], "entities": []}, {"text": "The Current age, years: Cumulative pack-years of smoking: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.72.", "labels": [], "entities": []}, {"text": "The RA duration, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 5.6.", "labels": [], "entities": []}, {"text": "The RA duration, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The RA duration, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 5.7.", "labels": [], "entities": []}, {"text": "The RA duration, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 8.4.", "labels": [], "entities": []}, {"text": "The RA duration, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The RA duration, years: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 9.0.", "labels": [], "entities": []}, {"text": "The RA duration, years: Cumulative pack-years of smoking: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.39.", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 4.0 (3.0 - 4.0).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 4.0 (3.0 - 17.5).", "labels": [], "entities": []}, {"text": "The CRP, median (IQR) mg/liter: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.61.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 5.0.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 3.3.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 5.3.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 2.6.", "labels": [], "entities": []}, {"text": "The Socioeconomic deprivation: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.77.", "labels": [], "entities": []}, {"text": "The ASES pain: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.9.", "labels": [], "entities": []}, {"text": "The ASES pain: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES pain: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 2.2.", "labels": [], "entities": []}, {"text": "The ASES pain: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.2.", "labels": [], "entities": []}, {"text": "The ASES pain: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES pain: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 2.0.", "labels": [], "entities": []}, {"text": "The ASES pain: Cumulative pack-years of smoking: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.36.", "labels": [], "entities": []}, {"text": "The ASES mood: Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 7.5.", "labels": [], "entities": []}, {"text": "The ASES mood: Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES mood: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 2.0.", "labels": [], "entities": []}, {"text": "The ASES mood: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 7.2.", "labels": [], "entities": []}, {"text": "The ASES mood: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The ASES mood: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 2.1.", "labels": [], "entities": []}, {"text": "The ASES mood: Cumulative pack-years of smoking: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.62.", "labels": [], "entities": []}, {"text": "The HADS anxiety: Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.7.", "labels": [], "entities": []}, {"text": "The HADS anxiety: Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The HADS anxiety: Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 3.4.", "labels": [], "entities": []}, {"text": "The HADS anxiety: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.7.", "labels": [], "entities": []}, {"text": "The HADS anxiety: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The HADS anxiety: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 4.0.", "labels": [], "entities": []}, {"text": "The HADS anxiety: Cumulative pack-years of smoking: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.97.", "labels": [], "entities": []}, {"text": "The HADS depression: Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 3.7.", "labels": [], "entities": []}, {"text": "The HADS depression: Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The HADS depression: Socioeconomic deprivation of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 1.9.", "labels": [], "entities": []}, {"text": "The HADS depression: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 4.8.", "labels": [], "entities": []}, {"text": "The HADS depression: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The HADS depression: Cumulative pack-years of smoking of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 3.5.", "labels": [], "entities": []}, {"text": "The HADS depression: Cumulative pack-years of smoking: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.36.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal: PSS stress of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 19.0.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal: PSS stress of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal: PSS stress of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 7.5.", "labels": [], "entities": []}, {"text": "The PSS stress: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 22.5.", "labels": [], "entities": []}, {"text": "The PSS stress: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The PSS stress: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 8.8.", "labels": [], "entities": []}, {"text": "The PSS stress: Exposed to indoor smoke at home: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.29.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal: HAQ of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 0.6.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal: HAQ of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal: HAQ of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 0.4.", "labels": [], "entities": []}, {"text": "The HAQ: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.9.", "labels": [], "entities": []}, {"text": "The HAQ: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The HAQ: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.8.", "labels": [], "entities": []}, {"text": "The HAQ: Exposed to indoor smoke at home: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.26.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal: Personal impact HAQ of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 2.0.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 1.4.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 2.5.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 2.2.", "labels": [], "entities": []}, {"text": "The Personal impact HAQ: Exposed to indoor smoke at home: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.52.", "labels": [], "entities": []}, {"text": "The EQ-VAS: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 76.3.", "labels": [], "entities": []}, {"text": "The EQ-VAS: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The EQ-VAS: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 15.6.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 70.8.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The EQ-VAS: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 19.2.", "labels": [], "entities": [{"text": "19.2", "start_pos": 147, "end_pos": 151, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.5646843314170837}]}, {"text": "The EQ-VAS: Exposed to indoor smoke at home: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.44.", "labels": [], "entities": []}, {"text": "The EQ-5D: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 0.7.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 0.2.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.7.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.2.", "labels": [], "entities": []}, {"text": "The EQ-5D: Exposed to indoor smoke at home: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.31.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 12.7.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.0.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 13.1.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.4.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy internal: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.85.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 14.3.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 3.5.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 13.7.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.2.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.77.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 3.8.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 1.6.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 4.3.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.9.", "labels": [], "entities": []}, {"text": "The Fagerstr\u20ac: om nicotine dependence: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.72.", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 3 (33).", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external: Exposed to indoor smoke at home of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 9 (31).", "labels": [], "entities": []}, {"text": "The Smoking self-efficacy external: Exposed to indoor smoke at home: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.00 \u2020.", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: CVD of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 1 (11).", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: CVD of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 3 (10).", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: CVD: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.00 \u2020.", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: COPD of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 1 (11).", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: COPD of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 2 (7).", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: COPD: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.00 \u2020.", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: Osteoporosis of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 1 (11).", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: Osteoporosis of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 6 (21).", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: Osteoporosis: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.00 \u2020.", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: ACPA positive of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 8 (89).", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: ACPA positive: 26 (90) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.00 \u2020.", "labels": [], "entities": []}, {"text": "The Exposed to indoor smoke at home: RF positive of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 7 (78).", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: RF positive: 23 (79) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.00 \u2020.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: Methotrexate of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 7 (78).", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: Methotrexate: 20 (69) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.00 \u2020.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: Any DMARD of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 7 (78).", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: Any DMARD: 27 (93) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 1.00 \u2020.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 0.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 4 (14).", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: 19 (66) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.55 \u2020.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 2 (22).", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: 19 (66) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.05 \u2020.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 5 (56).", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean: 12 (41) of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 0.70 \u2020.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Baseline demographics, disease and psychosocial factors associated with: Quitters has a value of 6 SD unless indicated otherwise.", "labels": [], "entities": []}, {"text": "The * Values are the number (percentage) or mean of Baseline demographics, disease and psychosocial factors associated with: Nonquitters has a value of 5 rheumatoid arthritis;.", "labels": [], "entities": []}]